Crouse to PreCision’s Board

William Crouse is joining the board of directors of PreCision Dermatology Inc., a Rhode Island-based maker of over the counter dermatology products. He is a general partner and former Managing Director of HealthCare Ventures, one of the world’s largest venture capital firms specializing in biotechnology.


CUMBERLAND, RI-PreCision Dermatology, Inc., a leader in developing and commercializing novel, prescription and over-the-counter products for improving skin health, announced today that healthcare industry veteran William W. Crouse has joined its Board of Directors. Mr. Crouse brings to PreCision more than 40 years of experience in venture capital investing and healthcare industry company management.

“Mr. Crouse is a respected and accomplished healthcare and investment executive with a proven track record in driving results at pharmaceutical and life sciences companies,” said Jeffrey Nugent, founding President and Chief Executive Officer of PreCision. “His vast knowledge of the dermatology industry, coupled with his financial acumen, will help us deliver value to our customers, partners and patients. We are confident that Mr. Crouse will serve as a resource for PreCision Dermatology as we execute against our strategic vision to become a leader in the growing field of skincare.”

He is a General Partner and former Managing Director of HealthCare Ventures, one of the world’s largest venture capital firms specializing in biotechnology.

From 1987 to 1993, Mr. Crouse served as Worldwide President of Ortho Diagnostic Systems, a subsidiary of Johnson & Johnson (J&J) that manufactures diagnostic tests for hospitals, and as Vice President of Johnson & Johnson International. Before joining J&J, Mr. Crouse led international operations and worldwide commercial development activities as Division Director at DuPont Pharmaceuticals Company. Prior to joining DuPont, he served as President of Revlon Health Care Group’s companies in Latin America, Canada, and Asia/Pacific. He also held numerous management positions at pharmaceutical company, E.R. Squibb & Sons.

Mr. Crouse currently serves on the Board of Directors for The Medicines Company, a publicly traded biotechnology company and Uluru Inc., a publicly traded wound care and drug delivery company. He is also on the Board of Directors of four private biotechnology companies and has previously served on numerous other biotechnology and pharmaceutical company boards, including ImClone Systems Inc., Human Genome Sciences Inc., Delysys Pharmaceutical Corporation and Allelix Biopharmaceuticals Inc. Mr. Crouse earned a B.S. in Finance and Economics from Lehigh University and an M.B.A. with Distinction in Marketing Management from Pace University.

Mr. Crouse’s appointment is effective immediately. He will be the sixth addition to the PreCision Dermatology Board of Directors.

About PreCision Dermatology, Inc.

Headquartered in Cumberland RI, PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology will expand quickly through acquisitions, in-licensing, co-marketing opportunities as well as internally generated therapies.